Myriad Genetics, Inc. Profile Avatar - Palmy Investing

Myriad Genetics, Inc.

Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health …

Medical - Diagnostics & Research
US, Salt Lake City [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Cash Amount Pay Date
Cash Amount Pay Date
End of MYGN's Analysis
CIK: 899923 CUSIP: 62855J104 ISIN: US62855J1043 LEI: - UEI: -
Secondary Listings
MYGN has no secondary listings inside our databases.